Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers. - Mughees M; Tacam M; Tan AW; Pitner MK; Iles LR; Hu X; Villodre ES; Debeb BG; Kogawa T; Lim B; Layman RM; Woodward WA; et al. (Molecular cancer therapeutics, 2025)